© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
November 21, 2016
Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.
Molar Pregnancy Survivor Shares Her Rare Cancer Story
Opdivo Regimen Pulled for Liver Cancer Treatment
Navigating Chronic Lymphocytic Leukemia Diagnosis and Staging
‘Treadmill of Survivorship’ With a Supportive Oncology Nurse